LOINC
Version 2.73

14558-1Mycobacterium tuberculosis DNA [Presence] in Gastric fluid by NAA with probe detectionActive

Part Descriptions

LP16659-2   Mycobacterium tuberculosis
Mycobacterium tuberculosis was discovered by Robert Koch in 1882 to be the infectious organism of tuberculosis (TB). Tuberculosis is a worldwide public health problem, especially in third world countries. The infection is classified as latent when the patient is asymptomatic and the infection is in a non-transmissible state. The active form of TB is transmissible and can be diagnosed by culturing the organism or by using molecular testing. Patients who are symptomatic have symptoms including fever, fatigue, loss of appetite, weight loss, persistent cough, and hemoptysis. Treatment of TB has been complicated by the emergence of drug-resistant strains which are present all over the world. Resistance to all of the drugs used to treat TB has occurred including the first line of treatment drugs isoniazid, rifampicin, pyrazinamide, and ethambutol. Some strains of TB have become resistant to more than one of the drugs used to treat TB, and are referred to as either multidrug-resistant TB (MDR-TB) or extensively drug-resistant TB (XDR-TB). MDR-TB are defined to be resistant to at least isoniazid and rifampicin. XDR-TB have worse disease symptoms and are resistant to isoniazid, rifampicin, any one of the fluoroquinolones, and any one of the three injectable second-line drugs amikacin, kanamycin, and capreomycin. The biggest risk factor for acquiring TB is to be infected by the human immunodeficiency virus (HIV). Twenty-five percent of all TB infections occur in patients also infected with HIV, and most of those occur in Africa. Social and behavioral determinants such as excessive alcohol use, smoking, and type 2 diabetes mellitus can increase the risk of contracting TB by two to three times.[https://www.nature.com/articles/nrdp201676] Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Regenstrief LOINC, Mycobacterium tuberculosis (Wikipedia)

LP16659-2   Mycobacterium tuberculosis
Mycobacterium tuberculosis (MTB) is a pathogenic bacterial species in the genus Mycobacterium and the causative agent of most cases of tuberculosis (TB). M. tuberculosis has an unusual, waxy coating on its cell surface (primarily mycolic acid), which makes the cells impervious to Gram staining, so acid-fast detection techniques are used, instead. The physiology of M. tuberculosis is highly aerobic and requires high levels of oxygen. Primarily a pathogen of the mammalian respiratory system, MTB infects the lungs. The most frequently used diagnostic methods for TB are the tuberculin skin test, acid-fast stain, and chest radiographs Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Mycobacterium tuberculosis (Wikipedia)

LP16659-2   Mycobacterium tuberculosis
A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Source: National Library of Medicine, MeSH 2006

Fully-Specified Name

Component
Mycobacterium tuberculosis DNA
Property
PrThr
Time
Pt
System
Gast fld
Scale
Ord
Method
Probe.amp.tar

Additional Names

Short Name
M tb DNA Gast Ql NAA+probe
Display Name
M. tuberculosis DNA NAA+probe Ql (Gast fld)
Consumer Name Alpha
Mycobacterium tuberculosis, Stomach fluid

Basic Attributes

Class
MICRO
Type
Laboratory
First Released
Version 1.0k
Last Updated
Version 2.63
Change Reason
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.
Order vs. Observation
Both

Language Variants Get Info

zh-CNChinese (China)
结核分枝杆菌 DNA:存在情况或阈值:时间点:胃液:序数型:探针法.基因扩增.靶向
nl-NLDutch (Netherlands)
Mycobacterium tuberculosis DNA:aanwezigheid:moment:maagvloeistof:ordinaal:moleculaire techniek (PCR)
fr-BEFrench (Belgium)
Mycobacterium tuberculosis ADN:PrThr:Temps ponctuel:Liquide gastrique:Ordinal:Sonde avec amplification de la cible
fr-CAFrench (Canada)
Mycobacterium tuberculosis , ADN:Présence-Seuil:Temps ponctuel:Liquide gastrique:Ordinal:Sonde avec amplification de la cible
fr-FRFrench (France)
Mycobacterium tuberculosis ADN:Présence/Seuil:Ponctuel:Liquide gastrique:Qualitatif:PCR amplification de cible
de-DEGerman (Germany)
Mycobacterium tuberculosis DNA:Nachweis oder Schwellenwert:Zeitpunkt:Magenflüssigkeit:Ordinal:Zielfragmentamplifikation mit Sondendetektion
it-ITItalian (Italy)
Mycobacterium tuberculosis DNA:PrThr:Pt:Gast fld:Ord:Sonda.amp.tar
ko-KRKorean (Korea, Republic of)
결핵균 디옥시리보핵산:임의농도:검사시점:위액:순위척도:DNA 탐색자.증폭.표적
pt-BRPortuguese (Brazil)
Mycobacterium tuberculosis DNA:ACnc:Pt:LiqGast:Ord:Sonda com limite de detecção da amplificação de alvo
ru-RURussian (Russian Federation)
Mycobacterium tuberculosis ДНК:PrThr:ТчкВрм:Желуд ждк:Пор:Проба.усил.миш
es-ARSpanish (Argentina)
ADN de Mycobacterium tuberculosis:concentración arbitraria:punto en el tiempo:líquidos/contenidos gástricos:ordinal:sonda.amplificación.blanco
es-MXSpanish (Mexico)
ADN de Mycobacterium tuberculosis:Presencia o umbral:Punto temporal:Fluido gástrico:Ordinal:Amplificación de ácidos nucleicos con detección de sonda
es-ESSpanish (Spain)
Mycobacterium tuberculosis ADN:PrThr:Punto temporal:Fluido gástrico:Ord:Sonda con amplificación dirigida
tr-TRTurkish (Turkey)
Mycobacterium tuberculosis DNA:MevcEşik:Zmlı:Gast sv:Srl:Prob.amf.hdf

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=14558-1